Scarica l'app Stockscreener
3.50
5.65%
-0.22
Dopo l'orario di chiusura:
3.50
Precedente Chiudi:
$3.72
Aprire:
$3.78
Volume 24 ore:
315.87K
Relative Volume:
0.73
Capitalizzazione di mercato:
$119.77M
Reddito:
-
Utile/perdita netta:
$-27.92M
Rapporto P/E:
-3.0348
EPS:
-1.1533
Flusso di cassa netto:
$-22.89M
1 W Prestazione:
+11.43%
1M Prestazione:
+27.64%
6M Prestazione:
-13.12%
1 anno Prestazione:
-70.55%
Intervallo 1D:
$3.50
$3.94
Intervallo di 1 settimana:
$3.11
$3.94
Portata 52W:
$2.13
$20.71
Sagimet Biosciences Inc Stock (SGMT) Company Profile
Nome
Sagimet Biosciences Inc
Settore
Industria
Telefono
(650) 561-8600
Indirizzo
155 BOVET RD., SUITE 303, SAN MATEO
Sagimet Biosciences Inc Borsa (SGMT) Ultime notizie
Sagimet Announces Oral Presentation at the 8th Annual MASH Drug Development Summit - GlobeNewswire
Sagimet Announces Oral Presentation at the 8th Annual MASH Drug Development Summit - StockTitan
There is no way Sagimet Biosciences Inc (SGMT) can keep these numbers up - SETE News
Sagimet Biosciences Inc (SGMT) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
What to expect from SGMT’s earnings report this quarter? - US Post News
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences - GlobeNewswire
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences - StockTitan
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences - Marketscreener.com
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences - Yahoo Finance
Should investors be concerned about Sagimet Biosciences Inc (SGMT)? - US Post News
Top investors say Sagimet Biosciences Inc (SGMT) ticks everything they need - SETE News
Sagimet Biosciences maintains buy rating on strong trial data - Investing.com
Price T Rowe Associates Inc. MD Takes Position in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
Sagimet Biosciences Inc. to Post Q3 2024 Earnings of ($0.52) Per Share, HC Wainwright Forecasts (NASDAQ:SGMT) - Defense World
Q3 2024 Earnings Forecast for Sagimet Biosciences Inc. (NASDAQ:SGMT) Issued By HC Wainwright - MarketBeat
Sagimet Biosciences Inc. (NASDAQ:SGMT) Forecasted to Earn Q3 2024 Earnings of ($0.43) Per Share - Defense World
Sagimet Biosciences initiates $75 million equity offering - Investing.com India
Sagimet Biosciences (NASDAQ:SGMT) Announces Quarterly Earnings Results - Defense World
ORG Partners LLC Purchases New Position in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
HC Wainwright Reiterates “Buy” Rating for Sagimet Biosciences (NASDAQ:SGMT) - Defense World
Sagimet Biosciences (NASDAQ:SGMT) PT Lowered to $32.00 - Defense World
Vanguard Group Inc. Purchases 894,319 Shares of Sagimet Biosciences Inc. (NASDAQ:SGMT) - MarketBeat
Vanguard Group Inc. Grows Stock Position in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
Financial Review: Lipella Pharmaceuticals (NASDAQ:LIPO) vs. Sagimet Biosciences (NASDAQ:SGMT) - Defense World
Sagimet Biosciences initiates $75 million equity offering By Investing.com - Investing.com Australia
Sagimet Biosciences initiates $75 million equity offering - Investing.com
Sagimet Biosciences (NASDAQ:SGMT) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat
Sagimet Biosciences (NASDAQ:SGMT) PT Lowered to $32.00 - MarketBeat
Sagimet Biosciences (NASDAQ:SGMT) Rating Reiterated by HC Wainwright - MarketBeat
Sagimet Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewswire
Sagimet Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
What's Going On With Sagimet Biosciences Stock On Thursday? - MSN
Sagimet Biosciences Inc. (SGMT): Should You Buy This New Penny Stock Now? - Insider Monkey
Sagimet Biosciences Inc. (SGMT): Should You Buy This New Penny Stock Now? - Yahoo Finance
10 Best New Penny Stocks To Buy Now - Insider Monkey
20,000 Shares in Sagimet Biosciences Inc. (NASDAQ:SGMT) Purchased by DekaBank Deutsche Girozentrale - Defense World
American International Group Inc. Grows Stock Holdings in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
O Shaughnessy Asset Management LLC Invests $72,000 in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
Sagimet Biosciences expands board, appoints two new directors - Investing.com India
Sagimet Biosciences expands board, appoints two new directors - Investing.com
Sagimet Biosciences Inc. Announces Appointment of Board of Directors - Marketscreener.com
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors - GlobeNewswire
SGMTSagimet Biosciences Inc. Latest Stock News & Market Updates - StockTitan
Sagimet Biosciences Expands Board with Two Key Appointments - TipRanks
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors - StockTitan
Sagimet Biosciences Inc [SGMT] Stock sold by Insider Kemble George for $74830.0 - Knox Daily
Sagimet Biosciences' Denifanstat Remains A Strong Buy Despite Eli Lilly's Tirzepatide - Seeking Alpha
Analysts Set Sagimet Biosciences Inc. (NASDAQ:SGMT) Target Price at $35.80 - MarketBeat
Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Acadian Asset Management LLC Makes New Investment in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
Insider Sales At Sagimet Biosciences Landed A Good Price - Simply Wall St
Sagimet Biosciences Inc Azioni (SGMT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sagimet Biosciences Inc Azioni (SGMT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Martins Eduardo Bruno | Chief Medical Officer |
Jul 19 '24 |
Sale |
3.10 |
8,357 |
25,910 |
81,213 |
| Rozek Elizabeth | General Counsel and CCO |
Jul 19 '24 |
Sale |
3.10 |
10,914 |
33,830 |
160,506 |
| Kemble George | Executive Chairman |
Jul 19 '24 |
Sale |
3.10 |
14,062 |
43,605 |
142,318 |
| Happel David | President & CEO |
Mar 26 '24 |
Buy |
5.27 |
12,100 |
63,731 |
639,200 |
| Happel David | President & CEO |
Dec 07 '23 |
Buy |
4.10 |
1,600 |
6,560 |
627,100 |
| Happel David | President & CEO |
Nov 16 '23 |
Buy |
2.35 |
590 |
1,386 |
590 |
1.10%
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):